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Abstract
Healthcare decision-making is a process that mainly depends on evidence and involves increasing numbers of 
stakeholders, including the consumers. Cochrane evidence responds to this challenge by identifying, appraising, 
integrating and synthesizing high-quality evidence. Recently, a collaborative effort has been initiated in Iran 
with Cochrane to establish a representative local entity. A variety of multifaceted interventions were conducted 
according to Cochrane’s strategy to 2020, such as producing evidence, making Cochrane evidence accessible, 
advocating for evidence and building an effective and sustainable organization. In this report, the authors 
present the two and half year performance and achievements of Cochrane Iran based on a comprehensive and 
systematic approach. This case might be an example of health diplomacy, which is initiated by a successful 
international collaboration and proceed with recognizing the importance of adherence to the strategic action 
plans and goals. 
Keywords: Cochrane, Evidence-Based Practice, Iran, Systematic Review, Health Policy
Copyright: © 2020 The Author(s); Published by Kerman University of Medical Sciences. This is an open-access 
article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/
licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the 
original work is properly cited.
Citation: Mesgarpour B, Aghababa S, Baradaran HR, et al. Achievements of the Cochrane Iran Associate 
Centre: lessons learned. Int J Health Policy Manag. 2020;9(6):222–228. doi:10.15171/ijhpm.2019.122
*Correspondence to:
Ali Akbar Haghdoost
Email: ahaghdoost@gmail.com
Article History:
Received: 2 September 2019
Accepted: 23 November 2019
ePublished: 11 December 2019
     Editorial
Full list of authors’ affiliations is available at the end of the article.
http://ijhpm.com
Int J Health Policy Manag 2020, 9(6), 222–228 doi 10.15171/ijhpm.2019.122
Introduction
Systematic reviews are being increasingly employed by 
health policy-makers, researchers and even patients to assist 
decision-making processes.1-4
Cochrane is known as an independent non-for-profit 
organization that plays a crucial mediating role in creating, 
evaluating and disseminating reliable, invaluable and practical 
information in the format of systematic reviews and meta-
analyses. With its well-deserved reputation, Cochrane has 
facilitated the use of applied research for practical purposes for 
more than two decades, including prevention, treatment and 
diagnosis.5 Cochrane potentially enables not only researchers 
to overcome low-value practices, but also other stakeholders 
to prohibit disinvestment decisions and assures them of the 
trustworthiness of its evidence.6 
The global and independent Cochrane network has 
geographic groups in 43 countries that promote and support 
the use of Cochrane evidence in health policy-making and 
practice. These groups act as a regional focus for the activities 
of the Cochrane network and support Cochrane members 
and supporters through different approaches, including, but 
not limited to, the provision of training and the promotion 
of accessibility to the Cochrane library.7 The experiences of 
Cochrane UK,8 Switzerland,9 Poland,10 Russia,11 Sweden,12 and 
China,13,14 which are reflected in their annual reports, consist 
of informative lessons to learn and benchmarks. 
Despite the small volume of systematic reviews in low- and 
middle-income countries,15 the efforts in Iran as a middle-
income country have been focused on promoting advocacy for 
evidence-based practices and making high-quality evidences 
accessible in this geographical region. 
A formal collaboration was therefore initiated with 
Cochrane. We encouraged our stakeholders to embark on the 
opportunities arising from this connection to Cochrane and 
made our performance a priority for the National Institute 
for Medical Research Development (NIMAD). This report 
describes the considerable achievements of Cochrane Iran 
Associate Centre over two and half years based on its strategic 
goals in line with Cochrane’s Strategy to 2020.
Cochrane Iran as Part of the Global Cochrane Network 
The idea of establishing Cochrane has been attributed to the 
British epidemiologist and medical doctor, Archibald Leman 
Cochrane, who made a ground-breaking contribution to 
the advocacy of randomized controlled trials in healthcare 
intervention research.16,17 The first systematic review in this 
field, entitled Effective Care in Pregnancy and Childbirth, was 
published 17 years later by Iain Chalmers, who was inspired 
by Cochrane.18 Eventually, the first Cochrane Centre was 
launched in 1993 in Oxford, UK.19 Currently, researchers, 
health professionals, patients, care providers and volunteers 
from more than 130 countries are involved in Cochrane as 
members (10 578) or supporters (61 099).20
To establish Cochrane Iran Associate Centre, NIMAD, 
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as representative of the Iranian Ministry of Health, and 
Cochrane entered into a Memorandum of Understanding, 
dated December 2017. The Cochrane Iran, which is mostly a 
network rather than a centre, is located in Tehran within the 
NIMAD. This centre was officially launched by the Iranian 
Minister of Health and Medical Education and welcomed the 
message of Cochrane’s Chief Executive Officer on April 5, 
2017. 
Achievements Based on Strategic Goals
In line with Cochrane’s strategy to 2020,2  the activities for 
associate centres are organized around Cochrane’s four key 
goals: producing evidence, making our evidence accessible, 
advocating for evidence and building an effective and 
sustainable organization. The strategic plan of Cochrane Iran 
has been modified according to the existing regional gaps 
and its performance has been elaborated as follows, which is 
summarized in Figure 1.
Goal 1. Producing Evidence
Cochrane Iran has promoted different types of Cochrane 
evidence, including Cochrane protocols and Cochrane 
reviews. This centre has also made efforts to build a bridge 
between high-quality evidence produced by Cochrane and 
the local stakeholders. Several national and international 
workshops were held, and access to the online learning 
resources of Cochrane served as an empowerment tool for 
the Cochrane authors. 
In-Person Events
Cochrane Iran has facilitated face-to-face training 
opportunities for authors and researchers based on a 
systematic needs assessment at national and regional levels. 
In the last two and half years, Cochrane Iran organized 37 
training courses around the country (in 10 sub-regions 
covering 64 medical universities). The titles of these 
workshops were extracted from the results of a national needs 
assessment and included “How to read a systematic review,” 
“How to develop a Cochrane protocol,” and “Basic level of 
evidence-based medicine.” A team of experts in the country 
coached these 2-3-day workshops; however, the course plan 
and training materials were provided by Cochrane Iran. 
Candidate registration and course evaluation were part of 
Cochrane Iran’s job, so as to make sure the standards were 
met.
Online Materials
Cochrane Iran has been distributing Cochrane’s online 
learning events, including webinars regularly held to raise 
awareness and offer opportunities to authors in Iran. The 
recorded webinars are published on a local video-sharing 
website entitled Aparat, because of limited access to YouTube 
in Iran. 
Publications 
Book: Cochrane Iran contributed to and supported the update 
of the best-selling Persian book entitled “Systematic review 
and meta-analysis,” published in 2019, which is one of the 
reference books for post-graduate students now.22 
Cochrane Protocols and Reviews: Cochrane Iran is promoting 
production of Cochrane evidence by Iranian researchers and 
monitoring the performance. Forty-eight Cochrane reviews 
and 33 Cochrane protocols with at least one author affiliated to 
Iran have been identified from 2004 to 2019. Since Cochrane 
reviews should be updated, there are several versions for each 
review, reaching a total of 110 publications. Nonetheless, 
seven reviews and seven protocols were withdrawn. The first 
Cochrane review protocol developed by Iranian authors was 
published in January 200523 and the first full systematic review 
appeared in the Cochrane library in January 2007.24
Paper: Thirteen Persian papers have been translated or 
their data extracted and evaluated for risk of bias and to 
ensure that they conform to the requirements of Cochrane 
review authors. These requests have been received by email or 
through the portal TaskExchange.
Research Grants
NIMAD introduced a top-paper grant in May 2018 for the 
first/corresponding author of papers published in Q1 or 
journals with IF = 6 or more, and the Cochrane Database of 
Systematic Reviews and Iranian authors would be the potential 
applicants of this grant. Receiving support for developing 
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Figure 1. Cochrane Iran’s Strategy to 2020.
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Cochrane review for Iranian authors who published their 
protocol up to one year ago has been added to the criteria 
of NIMAD Elite Grants in February 2018. These changes 
occurred following Cochrane Iran’s suggestion to NIMAD 
to hold several initiatives for supporting the production of 
Cochrane reviews by Iranian researchers.
Goal 2: Making Our Evidence Accessible 
In order to achieve this goal, Cochrane Iran has taken 
the responsibility of translating the Cochrane content 
into Persian. Although healthcare professionals are often 
capable of understanding English content, most of the 
other stakeholders, including patients, policy-makers and 
the media, require translated documents. Cochrane Iran 
supports access to the Cochrane library – the major product 
of Cochrane. 
Translation Project
Cochrane Iran had translated 2500 Cochrane abstracts into 
Persian by October 1, 2019. To achieve this figure, a translating 
team was made up of ten graduate medical students familiar 
with medical science issues and fluent in English. The 
translations of Cochrane abstracts into Persian consist of 
scientific abstracts and Cochrane Plain Language Summaries 
(PLS), which are targeted for the general population. Persian 
Figure 2. The Number of Translated Cochrane Abstracts and PLS Per 
Language, October 1, 2019. Abbreviation: PLS, Plain Language Summaries.
Table 1. The Top 10 Most Viewed Persian Cochrane Abstracts on Cochrane.ir, October 1, 2019
Rank Title of Cochrane Review DOI Views
1 Betahistine for symptoms of vertigo 10.1002/14651858.CD010696.pub2 241 952
2 Pregabalin for pain in fibromyalgia in adults 10.1002/14651858.CD011790.pub2 117 607
3 Gabapentin for fibromyalgia pain in adults 10.1002/14651858.CD012188.pub2 73 931 
4 Aripiprazole for autism spectrum disorders (ASD) 10.1002/14651858.CD009043.pub3 62 699 
5 Early versus delayed postoperative bathing or showering to prevent wound complications 10.1002/14651858.CD010075.pub3 55 293
6 Blood CEA levels for detecting recurrent colorectal cancer 10.1002/14651858.CD011134.pub2 45 743
7 Ganoderma lucidum (Reishi mushroom) for cancer treatment 10.1002/14651858.CD007731.pub3 40 549
8 D-dimer test for excluding the diagnosis of pulmonary embolism 10.1002/14651858.CD010864.pub2 39 677
9 Antidepressants and benzodiazepines for panic disorder in adults 10.1002/14651858.CD011567.pub2 29 740
10 Topical antibiotics for preventing surgical site infection in wounds healing by primary intention  10.1002/14651858.CD011426.pub2 24 531
Abbreviation: CEA, carcinoembryonic antigen.
is the third language of translated Cochrane abstracts, 
including PLS, in terms of the sheer number of translated 
abstracts (Figure 2). The numbers of translation vary across 
the languages because of different reasons such as earlier 
inception, financial resources and the capacity of dependent 
Cochrane centre(s).
These Persian abstracts have been published in the Persian 
Cochrane library on www.cochrane.ir and had been viewed 
more than two million times by March 2019. Table 1 presents 
the most viewed abstracts.
Cochrane Iran has engaged 21 volunteer translators up 
to now, who are mainly students of medical universities. To 
date, one of these translators has been interviewed as part of 
Cochrane’s 30 under 30 series. Furthermore, nine podcasts 
about popular Cochrane reviews have been translated and 
recorded by these volunteers. One of these podcasts, which 
was about Betahistin for the treatment of vertigo, has been 
ranked among the top viewed Cochrane podcasts of 2018, 
with more than 16 000 views. An interesting point is that the 
abstract corresponding to this podcast is also the top viewed 
Persian abstract (Table 1). The analysis of these views showed 
that most of them have been directed from a Google search. 
The Persian abstracts and podcasts have been disseminated 
through domestic channels, such as the social media. 
Furthermore, Persian has been added to the languages of 
Cochrane.org on October 1, 2019 and Cochrane website is 
now being translated into 15 languages.
Cochrane Library
Cochrane Iran has supported maintaining access to the 
Cochrane library for all medical universities and affiliated 
centres and teaching hospitals through the Ovid platform 
by way of a national subscription. Our collaborative effort 
has enhanced the access and utilization of the Cochrane 
library. We compared the top 40 out of 236 countries with 
the most frequent visits to the Cochrane library. Although 
Table 1 depicts a gentle decrease in the ranking of Iran, the 
number of visits implies a growth from 44 171 to 50 340 in 
2017 and 2018 (Table 2). The numbers, however, might have 
been underreported, since a considerable number of Iranians 
use virtual private networks to unblock restricted access to 
websites, which augmented after the 2018 US sanctions.
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Goal 3: Advocating for Evidence
Our team has promoted Cochrane and its work in Iran 
through the 10-subregional medical universities, which 
represent all 64 Iranian medical universities/schools. In 
2017, after introducing Cochrane Iran Associate Centre to 
Iranian medical universities, medical scholars and students 
were recommended to seek collaboration with Cochrane 
Iran. We also cooperated to promote the contribution of 
local researchers in joining the working groups of Iranian 
SYstematic REview Network (ISYREN) as an ancillary 
network of Cochrane Iran.
Media
The media plays a pivotal role in communication with people 
Table 2. Visits to the Cochrane Library by Country in 2017 and 2018
Country Visits (2017) Country Visits (2018)
United States 1 659 507 United States 2 116 429
United Kingdom 1 029 729 United Kingdom 1 301 034
Australia 542 378 Australia 671 740
Canada 286 378 Canada 356 171
India 222 172 India 317 507
Brazil 187 690 China 269 073
China 177 273 Spain 258 720
The Netherlands 153 125 Brazil 256 695
Spain 153 074 Germany 191 251
Germany 150 974 The Netherlands 184 920
Italy 134 235 Italy 165 316
Japan 111 039 Taiwan 154 832
Taiwan 107 564 Japan 152 975
France 95 615 Mexico 149 869
Mexico 90 355 France 123 512
Indonesia 77 410 Indonesia 99 161
New Zealand 74 464 Ireland 92 872
Ireland 73 252 Turkey 87 132
Thailand 68 299 New Zealand 86 984
Norway 66 662 Chile 83 167
Turkey 66 070 Thailand 82 279
Sweden 63 642 Norway 81 192
Belgium 61 049 Colombia 81 038
Malaysia 57 809 Malaysia 79 630
Switzerland 57 379 Sweden 78 377
South Korea 57 242 Belgium 72 976
Colombia 56 805 Philippines 70 890
Chile 54 068 Switzerland 70 139
Philippines 48 800 South Korea 67 402
Egypt 46 425 Singapore 65 062
South Africa 45 262 Egypt 61 904
Denmark 44 391 Russian Federation 61 688
Singapore 44 207 Argentina 60 566
Iran 44 171 Denmark 57 407
Russian Federation 41 126 South Africa 53 827
Portugal 37 604 Peru 52 775
Saudi Arabia 36 116 Iran 50 340
Argentina 35 859 Hong Kong 50 021
Hong Kong 34 914 Portugal 46 961
Peru 34 084 Saudi Arabia 46 592
and presents a window of opportunity to researchers to face 
a broad general audience in the community. Cochrane Iran 
embraces this potential value in order to present Cochrane 
products. The following types of media represent our efforts 
to provide scientific news, information and evidence for the 
public. 
Newspapers: We have published two feature articles in 
Salamat newspaper – weekly newspaper in healthcare – 
entitled “Systematic review of the benefits of Yoga for health: 
What do researchers say about Yoga?” and “Cochrane 
recommendations on postoperative knowledge: Three points 
to follow after surgery.” These features depicted Cochrane 
evidence in a plain language for the public with a description 
of Cochrane Iran and its Persian library.
Webpage: We created iran.cochrane.org as a sub-domain 
of cochrane.org and cochrane.ir as a local host specified for 
the dissemination of translated abstracts (Iranian Cochrane 
Library). In its local host, this website might increase the 
retrieval of Persian Cochrane abstracts for people searching 
Persian words in search engines such as Google. The most 
viewed abstracts are retrieved in the top ten Google records 
following the search of particular medication names. The 
traffic analysis of cochrane.ir indicates that it has more than 
3000 visits per day. The traffic analysis of cochrane.ir indicates 
that it has more than 5000 visits per day. Furthermore, 723 
pages from 74 websites have a link to 295 target pages on this 
website, making the website rank much more improved.
Social media: Popular social media networks, such as 
Telegram, Instagram, Twitter, and Aparat were used to 
introduce Cochrane Iran to the local community (Table 3).
Public and Professional Events
Cochrane Iran has been introduced to health and medical 
researchers from May 2017 to October 2019 in more than 
21 scientific events, including workshops, seminars and 
conferences. Moreover, Cochrane Iran has put tremendous 
effort into the translation of the book of Testing Treatments, 
which promotes the understanding and evaluation of health 
treatment by the public and patients. The website called 
Testing Treatments Interactive, which has been translated 
into 14 languages, provides a valuable resource for developing 
critical thinking in treatment claims. The launch plan of 
the Persian website accompanies the launch of the Persian 
translation of the book Testing Treatments in the early 2020.
Collaborations
Involving consumer’s and health professionals’ associations 
in advocating for evidence has been defined as a goal in 
Cochrane Iran’s strategic plan. An agreement was reached 
with the Medical Council of the Islamic Republic of Iran in 
Table 3. Cochrane Iran Statistics in the Social Media, October 1, 2019
Telegram Channel: 118 posts, 886 subscribers, 161 851 views
Aparat Channel: 127 videos, 13 followers, 15 265 views
Instagram: 59 posts, 254 followers
Twitter: 103 posts, 148 followers
Mesgarpour et al
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June 2019 and a meeting has so far been planned with the 
Commission of Medical Scientific Associations. 
Goal 4: Building an Effective and Sustainable Organization
Cochrane Iran endeavours to be a diverse, inclusive and 
transparent that provides all Cochrane citizen scientists with 
adequate enthusiasm and skills an opportunity to support this 
national organization. This centre is guided by the Cochrane 
principles, governed accountably and managed efficiently and 
strives for the optimal use of its resources.
Promoting Researchers’ Participation
The analysis of the characteristics of 996 Cochrane members 
who were affiliated to an Iranian university/institute showed 
a significant increase in the number of registered members 
or supporters in the recent years, from 52 in 2016 to 251 and 
388 in 2017 and 2018, respectively (Figure 3). This growth 
is mostly due to Cochrane’s new membership scheme, ie, the 
Membership Project that launched in 2017 (n = 618, 62%). 
Figure 4 illustrates the primary groups of Cochrane’s Iranian 
members, which were classified into one out of eight Cochrane 
networks. This figure shows that 329 (33%) of the members 
have joined in a Review Group, 14 in the Consumer Network, 
five in Trainers’ Networks, six in Methods Groups and two 
in Cochrane Fields. Iranian members play a part in 48 out of 
the 52 Cochrane Review Groups. The “Schizophrenia Group,” 
“Heart Group,” “Back and Neck Group,” and “Cystic Fibrosis 
and Genetic Disorders Group” have the highest number of 
members (37, 22, 16, and 16, respectively). The five methods 
groups include “Equity Methods Group” with two members 
and the “Adverse Effects Methods Group,” “Economics Methods 
Group,” “Editorial and Methods Department” and “Information 
Retrieval Methods Group.” The two Cochrane fields include 
“Cochrane Child Health” and “Cochrane Rehabilitation.”
Promoting Medical Universities’ Participation
Iranian medical universities have been encouraged to build 
an internal network of contributors to systematic reviews 
(ISYREN) in the following groups and define their strengths 
and gaps. 
• Review methods 
• Search and information retrieval
• Knowledge translation and communicating evidence
• Data extraction
• Quality assessment
• Statistical methods
Iran University of Medical Sciences, Tehran, Iran and Shahid 
Beheshti University of Medical Sciences, Tehran, Iran have 
initiated their network. Kermanshah University of Medical 
Sciences, Kermanshah, Iran is working on establishing a 
Figure 3. The Trend of Researchers With an Iranian Affiliation Who Are Contributing to Cochrane.
Figure 4. The Number of Iranian Researchers With a Role in Cochrane Review Networks, Method Groups and Fields.
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research centre on systematic reviews. Nevertheless, the 
lack of human and institutional capacity-building affects the 
outcome of these university networks.
Conclusion
The present report aimed to describe and highlight the 
two-year achievements of Cochrane Iran according to 
the predefined goals. Cochrane Iran has been using a 
comprehensive approach to promote the valiant attempts 
of Iranian researchers with sustained efforts to produce 
and implement high-quality evidence under Cochrane’s 
leadership. The experience of NIMAD to building up a branch 
of an international organization in Iran has been relatively 
successful. The key for effective collaboration with the 
Cochrane network might be developing a strategic plan and 
being committed to the goals and values of the organization. 
NIMAD also provided an opportunity for Cochrane Iran 
to network with universities academic staff and present its 
program in several events. Furthermore, producing Cochrane 
abstracts in Persian might have increased access to the high-
quality health evidence by healthcare providers, professionals, 
and workers as well as patients and family carers. Having 
support from a national granting body to initiate Cochrane 
Iran activities, cooperation with Ministry of Health, building 
a network with medical universities/research centres, holding 
workshops for different target groups, being involve in 
updating a national reference book in Persian, and being 
inclusive in collaboration with all interested individuals were 
fruitful lessons, which can be learned from our experiences. 
The efforts of the centre, based on the four goals could reflect 
Cochrane knowledge translation of goals in Iran. However, 
to align with Cochrane Strategy 2020 and to put Cochrane 
evidence at the heart of health decision-making in Iran, our 
team has yet a lot more to work on. Cochrane Iran can be 
strengthened through the following steps:
• Supporting health policy-makers to use Cochrane 
evidence 
• Making Persian abstracts of Cochrane reviews more 
accessible to the decision-makers
• Improving advocacy in the social media 
• Promoting the grading quality of evidence and the 
strength of the recommendations, including guidelines 
provided by the national health technology assessment 
entities
• Building the capacity in Cochrane Iran volunteers to 
engage more in knowledge translation activities.
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